Reuters logo
BRIEF-Ose Immunotherapeutics receives €2.6 million after new milestone for its product OSE-127
June 21, 2017 / 4:35 PM / 5 months ago

BRIEF-Ose Immunotherapeutics receives €2.6 million after new milestone for its product OSE-127

June 21 (Reuters) - OSE IMMUNOTHERAPEUTICS SA:

* OSE IMMUNOTHERAPEUTICS RECEIVES PAYMENT OF €2.6 MILLION FROM BPIFRANCE AFTER COMPLETION OF A NEW KEY MILESTONE FOR ITS PRODUCT OSE-127 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below